Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma

Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma

Background and aimsGenetic polymorphisms within the promoter of interferon-α receptor type-1 (IFNAR1) have been associated with the susceptibility to and the outcome of chronic hepatitis B virus (HBV) infection. However, the impact of these polymorphisms in the transcriptome of the HBV-associated he...

Full description

Bibliographic Details
Main Authors:	Timokratis Karamitros, George Papatheodoridis, Dimitrios Paraskevis, Angelos Hatzakis, Jean L. Mbisa, Urania Georgopoulou, Paul Klenerman, Gkikas Magiorkinis
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-04-01
Series:	Frontiers in Immunology
Subjects:	hepatitis virus B interferon-α receptor type-1 promoter hepatocellular carcinoma interferon-α receptor polymorphism transcriptome
Online Access:	http://journal.frontiersin.org/article/10.3389/fimmu.2018.00777/full

Similar Items

Impact of interferon-alpha receptor-1 promoter polymorphisms on the transcriptome of the hepatitis B virus-associated hepatocellular carcinoma
by: Karamitros, T, et al.
Published: (2018)

Editorial: Structures, Signaling Mechanisms, and Functions of Types I and III Interferons
by: Ronald L. Rabin, et al.
Published: (2021-02-01)

Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation
by: Elisabeth Müller, et al.
Published: (2018-11-01)

Association of SNPs In Interferon Receptor Genes in Chronic Hepatitis C with Response to Combined Therapy of Interferon and Ribavirin
by: Zohreh Heidari, et al.
Published: (2014-10-01)

Nanopore sequencing and full genome de novo assembly of human cytomegalovirus TB40/E reveals clonal diversity and structural variations
by: Timokratis Karamitros, et al.
Published: (2018-08-01)

Interferon-Inducible Protein 16 (IFI16) Has a Broad-Spectrum Binding Ability Against ssDNA Targets: An Evolutionary Hypothesis for Antiretroviral Checkpoint
by: Tara Patricia Hurst, et al.
Published: (2019-07-01)

De Novo Assembly of Human Herpes Virus Type 1 (HHV-1) Genome, Mining of Non-Canonical Structures and Detection of Novel Drug-Resistance Mutations Using Short- and Long-Read Next Generation Sequencing Technologies.
by: Timokratis Karamitros, et al.
Published: (2016-01-01)

Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma
by: Maria Bousali, et al.
Published: (2021-08-01)

Interferon α (IFN-α) vs. the combination IFN-α and octreotide LAR in the treatment of patients with well differentiated neuroendocrine tumors (NET) of various localizations
by: G S Yemelyanova, et al.
Published: (2017-06-01)

Hepatitis B Virus Integration into Transcriptionally Active Loci and HBV-Associated Hepatocellular Carcinoma
by: Maria Bousali, et al.
Published: (2022-01-01)

Interferon alpha, gamma, and lambda 2: are they possible culprits in the association between psoriasis and hepatitis C virus?
by: Randa Youssef, et al.
Published: (2019-01-01)

Interferon-α action in cytokine profile in eosinophilic nasal polyp cultures
by: Júlio Cláudio Sousa, et al.
Published: (2021-05-01)

B. C. G. plus recombinant interferon α2b in superficial bladder cancer
by: Gyan Prakash Singh, et al.
Published: (2001-01-01)

The role of interferon-gamma and interferon-gamma receptor in tuberculosis and nontuberculous mycobacterial infections
by: Jalaledin Ghanavi, et al.
Published: (2021-01-01)

Function and Modulation of Type I Interferons during Respiratory Syncytial Virus Infection
by: Laura M. Stephens, et al.
Published: (2020-04-01)

The Key Roles of Interferon Lambda in Human Molecular Defense against Respiratory Viral Infections
by: Alexey A. Lozhkov, et al.
Published: (2020-11-01)

The interferon receptor-1 promoter polymorphisms affect the outcome of Caucasians with HBeAg-negative chronic HBV infection
by: Karamitros, T, et al.
Published: (2015)

Interferon-α Subtypes As an Adjunct Therapeutic Approach for Human Immunodeficiency Virus Functional Cure
by: Jeffy George, et al.
Published: (2018-02-01)

Diagnostic Accuracy of Methods for Detection of Antibodies against Type I Interferons in Patients with Endocrine Disorders
by: Nurana Nuralieva, et al.
Published: (2022-11-01)

Method for quantification of porcine type I interferon activity using luminescence, by direct and indirect means
by: Michael Puckette, et al.
Published: (2022-03-01)

Unraveling the Link between Interferon-α and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies
by: Barbara Infante, et al.
Published: (2022-12-01)

Evaluation of the effect of soybean diet on interferon-α-induced depression in male mice
by: Yazdan Azimi Fashi, et al.
Published: (2017-08-01)

Toll-like receptor 2-mediated downstream cytokine levels as determinant of malaria pathogenesis
by: Manash Pratim Kalita, et al.
Published: (2023-01-01)

Combined Interferon-α and Inosiplex Treatment of Subacute Sclerosing Panencephalitis: A Case Report
by: Chy-Yuan Han, et al.
Published: (2003-08-01)

The interferons : characterization and application /
by: Meager, Anthony
Published: (2006)

Pegylated-interferon-alpha treatment modulating the immune response of cytotoxic lymphocytes in cervical intraepithelial neoplasia
by: Letícia Montes Stark, et al.
Published: (2021-06-01)

Curcumin assists anti-EV71 activity of IFN-α by inhibiting IFNAR1 reduction in SH-SY5Y cells
by: Yanfang Wang, et al.
Published: (2022-02-01)

Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C
by: Maria Helena Postal Pavan, et al.

Influence of Canonical and Non-Canonical IFNLR1 Isoform Expression on Interferon Lambda Signaling
by: John Grayson Evans, et al.
Published: (2023-02-01)

Interferon-α2a treatment for refractory Behçet's disease
by: Yung Jen Lai, et al.
Published: (2018-01-01)

Hepatitis C virus resistance to interferon therapy: an alarming situation
by: Kanwal Sobia, et al.
Published: (2014-12-01)

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
by: Ioannis Varbobitis, et al.
Published: (2016-09-01)

Association between IFNGR1 gene polymorphisms and tuberculosis susceptibility: A meta-analysis
by: Liwei Cheng, et al.
Published: (2022-09-01)

Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
by: Yuliya V. Katlinskaya, et al.
Published: (2016-04-01)

Changes and significance of TLR7/9 and IFN-Ⅰ levels in children with severe mycoplasma pneumoniae pneumonia
by: Yan Jiangxue, Ding Xia, Jiao Qiongjie, Huang Li, Cao Nannan, Dong Xinfang, Ni Qian
Published: (2023-03-01)

Clinical Analysis of Polyethylene Glycol Interferon-α Treatment in 155 Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) Patients
by: Xin Luo, et al.
Published: (2017-11-01)

Microglial responses to peripheral type 1 interferon
by: Ernest Aw, et al.
Published: (2020-11-01)

The potential influence of interferon-α on the growth of the growing teratoma: A case report
by: Akinobu Katami, et al.
Published: (2022-11-01)

Topical Interferon Alpha 2b in the Treatment of Refractory Diabetic Macular Edema
by: Arash Maleki, et al.
Published: (2020-10-01)

Using quantitative MRI to study brain responses to immune challenge with interferon-α
by: Maria Antonietta Nettis, et al.
Published: (2021-12-01)